Capricor Therapeutics, Inc.
CAPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $453,891 | $433,095 | $486,022 |
| - Cash | $19,510 | $23,241 | $28,795 | $11,287 |
| + Debt | $14,423 | $1,044 | $1,249 | $1,451 |
| Enterprise Value | – | $431,694 | $405,550 | $476,186 |
| Revenue | $0 | $0 | $0 | $11,131 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$20,359 | -$22,047 | -$18,916 | -$3,424 |
| % Margin | – | – | – | -30.8% |
| EBITDA | -$24,076 | -$27,233 | -$24,577 | -$7,322 |
| % Margin | – | – | – | -65.8% |
| Net Income | -$24,571 | -$25,911 | -$24,392 | -$7,117 |
| % Margin | – | – | – | -63.9% |
| EPS Diluted | -0.54 | -0.57 | -0.53 | -0.16 |
| % Growth | 5.3% | -7.5% | -231.3% | – |
| Operating Cash Flow | $0 | -$20,122 | -$6,434 | -$14,796 |
| Capital Expenditures | $0 | -$1,450 | -$1,140 | -$735 |
| Free Cash Flow | $0 | -$21,572 | -$7,574 | -$15,531 |